These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 12224984)

  • 1. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.
    De Korte J; Mombers FM; Sprangers MA; Bos JD
    Arch Dermatol; 2002 Sep; 138(9):1221-7; discussion 1227. PubMed ID: 12224984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature.
    Bronsard V; Paul C; Prey S; Puzenat E; Gourraud PA; Aractingi S; Aubin F; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Richard-Lallemand MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():17-22. PubMed ID: 20443996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
    Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
    Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.
    Lee EH; Klassen AF; Nehal KS; Cano SJ; Waters J; Pusic AL
    J Am Acad Dermatol; 2013 Aug; 69(2):e59-67. PubMed ID: 23102770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical review of generic and dermatology-specific health-related quality of life instruments.
    Both H; Essink-Bot ML; Busschbach J; Nijsten T
    J Invest Dermatol; 2007 Dec; 127(12):2726-39. PubMed ID: 17989733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
    Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
    Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life assessments in dermatology.
    Finlay AY
    Semin Cutan Med Surg; 1998 Dec; 17(4):291-6. PubMed ID: 9859917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results.
    Augustin M; Wenninger K; Amon U; Schroth MJ; Küster W; Chren M; Kupfer J; Gieler U
    Dermatology; 2004; 209(1):14-20. PubMed ID: 15237262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.
    de Tiedra AG; Mercadal J; Badía X; Mascaró JM; Lozano R
    Pharmacoeconomics; 1998 Oct; 14(4):405-22. PubMed ID: 10344908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis.
    Finlay AY; Salek MS; Haney J;
    Dermatology; 2003; 206(4):307-15. PubMed ID: 12771471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
    He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics.
    Mørk C; Wahl A; Moum T
    Acta Derm Venereol; 2002; 82(5):347-51. PubMed ID: 12430733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Creation and cross-cultural adaptation of the Ukrainian versions of SKINDEX-29, SKINDEX-16 questionnaires, Psoriasis Disability Index and further validation of the Ukrainian version of the Dermatology Life Quality Index].
    Chernyshov PV
    Lik Sprava; 2009; (1-2):95-8. PubMed ID: 19953996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.
    Ali FM; Cueva AC; Vyas J; Atwan AA; Salek MS; Finlay AY; Piguet V
    Br J Dermatol; 2017 Mar; 176(3):577-593. PubMed ID: 27273146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
    Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
    Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials.
    McKenna SP; Cook SA; Whalley D; Doward LC; Richards HL; Griffiths CE; Van Assche D
    Br J Dermatol; 2003 Aug; 149(2):323-31. PubMed ID: 12932239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial.
    Ellis CN; Mordin MM; Adler EY;
    Am J Clin Dermatol; 2003; 4(2):131-9. PubMed ID: 12553852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients.
    Nijsten T; Meads DM; de Korte J; Sampogna F; Gelfand JM; Ongenae K; Evers AW; Augustin M
    J Invest Dermatol; 2007 Oct; 127(10):2315-22. PubMed ID: 17495953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.